OBJECTIVES: To evaluate whether race influences agreement between screening results and documentation of cognitive impairment and delirium. DESIGN: Secondary data analysis. SETTING: An urban, public hospital and healthcare system. PARTICIPANTS: Hospitalized older adults aged 65 and older admitted to general inpatient medical services evaluated for cognitive impairment (n = 851) and evaluated for delirium (n = 424). MEASUREMENTS: Cognitive impairment and delirium were measured in each participant using the Short Portable Mental Status Questionnaire (SPMSQ) and the Confusion Assessment Method (CAM), respectively, as the reference identification method. Clinical documentation of cognitive impairment and delirium was defined according to the presence of International Classification of Diseases, Ninth Revision (ICD-9), codes from within 1 year before hospitalization through discharge for cognitive impairment or from hospital admission through discharge for delirium. RESULTS: Two hundred ninety-four participants (34%) had cognitive impairment based on SPMSQ performance, and 163 (38%) had delirium based on CAM results. One hundred seventy-one (20%) of those with cognitive impairment had an ICD-9 code for cognitive impairment, whereas 92 (22%) of those with delirium had an ICD-9 code for delirium. After considering age, sex, education, socioeconomic status, chronic comorbidity, and severity of acute illness, of those who screened positive on the SPMSQ, African Americans had a higher adjusted odds ratio (AOR) than non-African Americans for clinical documentation of cognitive impairment (AOR = 1.66, 95% confidence interval (CI) = 0.95-2.89), and of those who screened negative on the SPMSQ, African Americans had higher odds of clinical documentation of cognitive impairment (AOR = 2.10, 95% CI = 1.17-3.78) than non-African Americans. There were no differences in clinical documentation rates of delirium between African Americans and non-African Americans. CONCLUSION: Racial differences in coding for cognitive impairment may exist, resulting in higher documentation of cognitive impairment in African Americans screening positive or negative for cognitive impairment.
OBJECTIVES: To evaluate whether race influences agreement between screening results and documentation of cognitive impairment and delirium. DESIGN: Secondary data analysis. SETTING: An urban, public hospital and healthcare system. PARTICIPANTS: Hospitalized older adults aged 65 and older admitted to general inpatient medical services evaluated for cognitive impairment (n = 851) and evaluated for delirium (n = 424). MEASUREMENTS: Cognitive impairment and delirium were measured in each participant using the Short Portable Mental Status Questionnaire (SPMSQ) and the Confusion Assessment Method (CAM), respectively, as the reference identification method. Clinical documentation of cognitive impairment and delirium was defined according to the presence of International Classification of Diseases, Ninth Revision (ICD-9), codes from within 1 year before hospitalization through discharge for cognitive impairment or from hospital admission through discharge for delirium. RESULTS: Two hundred ninety-four participants (34%) had cognitive impairment based on SPMSQ performance, and 163 (38%) had delirium based on CAM results. One hundred seventy-one (20%) of those with cognitive impairment had an ICD-9 code for cognitive impairment, whereas 92 (22%) of those with delirium had an ICD-9 code for delirium. After considering age, sex, education, socioeconomic status, chronic comorbidity, and severity of acute illness, of those who screened positive on the SPMSQ, African Americans had a higher adjusted odds ratio (AOR) than non-African Americans for clinical documentation of cognitive impairment (AOR = 1.66, 95% confidence interval (CI) = 0.95-2.89), and of those who screened negative on the SPMSQ, African Americans had higher odds of clinical documentation of cognitive impairment (AOR = 2.10, 95% CI = 1.17-3.78) than non-African Americans. There were no differences in clinical documentation rates of delirium between African Americans and non-African Americans. CONCLUSION: Racial differences in coding for cognitive impairment may exist, resulting in higher documentation of cognitive impairment in African Americans screening positive or negative for cognitive impairment.
Authors: M X Tang; P Cross; H Andrews; D M Jacobs; S Small; K Bell; C Merchant; R Lantigua; R Costa; Y Stern; R Mayeux Journal: Neurology Date: 2001-01-09 Impact factor: 9.910
Authors: Malaz A Boustani; Noll L Campbell; Babar A Khan; Greg Abernathy; Mohammed Zawahiri; Tiffany Campbell; Jason Tricker; Siu L Hui; John D Buckley; Anthony J Perkins; Mark O Farber; Christopher M Callahan Journal: J Gen Intern Med Date: 2012-05 Impact factor: 5.128
Authors: Shahid Shafi; Carlos Marquez de la Plata; Ramon Diaz-Arrastia; Aaron Bransky; Heidi Frankel; Alan C Elliott; Jennifer Parks; Larry M Gentilello Journal: J Trauma Date: 2007-11
Authors: Guy G Potter; Brenda L Plassman; James R Burke; Mohammed U Kabeto; Kenneth M Langa; David J Llewellyn; Mary A M Rogers; David C Steffens Journal: Alzheimers Dement Date: 2009-11 Impact factor: 21.566
Authors: Babar A Khan; Anthony Perkins; Siu L Hui; Sujuan Gao; Noll L Campbell; Mark O Farber; Malaz A Boustani Journal: Crit Care Med Date: 2016-09 Impact factor: 7.598
Authors: Dae Hyun Kim; Jung Lee; Caroline A Kim; Krista F Huybrechts; Brian T Bateman; Elisabetta Patorno; Edward R Marcantonio Journal: Pharmacoepidemiol Drug Saf Date: 2017-05-09 Impact factor: 2.890
Authors: Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant Journal: Alzheimers Dement Date: 2018-12-13 Impact factor: 21.566
Authors: Jacqueline M Torres; Danielle Hessler-Jones; Carol Yarbrough; Adam Tapley; Raemarie Jimenez; Laura M Gottlieb Journal: BMC Med Inform Decis Mak Date: 2019-06-20 Impact factor: 2.796